» Articles » PMID: 38053960

The Role of AGT, AMPD1, HIF1α, IL-6 Gene Polymorphisms in the Athletes' Power Status: A Meta-Analysis

Overview
Journal J Hum Kinet
Publisher Termedia
Date 2023 Dec 6
PMID 38053960
Authors
Affiliations
Soon will be listed here.
Abstract

This meta-analysis was designed to investigate the relationship between genetic polymorphisms (AGT rs699, AMPD1 rs17602729, HIF1α rs11549465, IL-6 rs1800795) and power athletes' status. Only case-control studies were included in the meta-analysis. A systematic search of the PubMed and Web of Science databases was performed to identify relevant studies and 23 studies met the inclusion criteria for the meta-analysis. The data from the included studies were pooled and analyzed using a random effects or fix effects model. The effect size was calculated as the odds ratio or a risk ratio with 95% confidence intervals. The results showed that certain genetic polymorphisms, AGT rs699 Thr allele, HIF1A rs11549465 Ser allele and AMPD1 rs17602729 C allele, were significantly more prevalent in power athletes (p < 0.05). When examining the genotype frequency distribution of AGT rs699 and AMPD1 rs17602729, significant differences were found in both the dominant and recessive models (p < 0.05). The results indicate that these gene polymorphisms play a role in power athlete status, however, new and more comprehensive studies are needed to confirm these results.

Citing Articles

Candidate gene polymorphisms and power athlete status: a meta-analytical approach.

Ipekoglu G, Cetin T, Sirtbas T, Kilic R, Odabasi M, Bayraktar F J Physiol Biochem. 2025; .

PMID: 40055285 DOI: 10.1007/s13105-025-01071-0.


Impact of the C > T Polymorphism on Selected Variables of Aerobic and Anaerobic Capacity after a 12-Week Training Program.

Leonska-Duniec A, Maculewicz E, Massidda M, Buryta M, Mastalerz A, Cieszczyk P J Hum Kinet. 2024; 94:117-125.

PMID: 39563773 PMC: 11571456. DOI: 10.5114/jhk/191847.


Genetic insights into endurance athlete status: A meta-analysis of gene polymorphisms.

Ipekoglu G, Ari E, Aydogdu A, Korkmaz F, Celik H, Ozturk F J Biol Methods. 2024; 11(3):e99010021.

PMID: 39544188 PMC: 11557301. DOI: 10.14440/jbm.2024.0013.


Examining the relationship between genetic polymorphisms (BDKRB2, GNB3, HIF1A, MCT1, NOS3) and endurance athlete status.

Ipekoglu G, Apaydin N, Cetin T, Eren A, Topcu P, Yucelsoy B Eur J Appl Physiol. 2024; 124(7):1943-1958.

PMID: 38753016 PMC: 11199302. DOI: 10.1007/s00421-024-05498-z.

References
1.
Tanimoto K, Yoshiga K, Eguchi H, Kaneyasu M, Ukon K, Kumazaki T . Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance. Carcinogenesis. 2003; 24(11):1779-83. DOI: 10.1093/carcin/bgg132. View

2.
Bosnyak E, Trajer E, Alszaszi G, Mora A, Gyore I, Udvardy A . Lack of association between the GNB3 rs5443, HIF1A rs11549465 polymorphisms, physiological and functional characteristics. Ann Hum Genet. 2020; 84(5):393-399. DOI: 10.1111/ahg.12387. View

3.
Maciejewska-Skrendo A, Mieszkowski J, Kochanowicz A, Niespodzinski B, Cieszczyk P, Leznicka K . Does the Intron 7 Gene Variant (rs4253778) Influence Performance in Power/Strength-Oriented Athletes? A Case-Control Replication Study in Three Cohorts of European Gymnasts. J Hum Kinet. 2021; 79:77-85. PMC: 8336554. DOI: 10.2478/hukin-2020-0060. View

4.
Rubio J, Martin M, Rabadan M, Gomez-Gallego F, San Juan A, Alonso J . Frequency of the C34T mutation of the AMPD1 gene in world-class endurance athletes: does this mutation impair performance?. J Appl Physiol (1985). 2005; 98(6):2108-12. DOI: 10.1152/japplphysiol.01371.2004. View

5.
Pranckeviciene E, Gineviciene V, Jakaitiene A, Januska L, Utkus A . Total Genotype Score Modelling of Polygenic Endurance-Power Profiles in Lithuanian Elite Athletes. Genes (Basel). 2021; 12(7). PMC: 8306147. DOI: 10.3390/genes12071067. View